Drug intelligence / Profile preview

multi-target peptide vaccine

Development stage
Preclinical
Lead developer
Hebei Bio-High Technology Development
Modality
Peptides, Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal
01

Overview

Multi-target peptide vaccine is a preclinical therapeutic cancer vaccine candidate under development by Hebei Bio-High Technology Development, in collaboration with Jiuzhou Pharmaceutical and the research team of Professor Yu Jun at The Chinese University of Hong Kong. The vaccine is designed to target gastrointestinal tumors by incorporating multiple tumor-associated peptide antigens intended to stimulate a specific anti-tumor immune response. The program is currently in the preclinical stage, focusing on identifying and validating optimal peptide targets for gastrointestinal malignancies.

Other names
多肽疫苗类药物gastrointestinal tumor peptide vaccine
02

Targets

Major histocompatibility complex peptide-binding grooveγδ TCR (T-cell receptor)

Beyond the preview

Go deeper on multi-target peptide vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multi-target peptide vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call